Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Seung-Chul Lee is a pioneering surgeon whose work has fundamentally advanced the field of robotic endocrine and gastrointestinal surgery. His primary research focuses on the development and validation of minimally invasive robotic techniques, particularly for thyroid and colorectal cancers. Dr. Lee’s most significant contribution is his leadership in establishing the gasless, transaxillary approach for robotic thyroidectomy, a technique that eliminates visible neck scars. His landmark paper, "Robotic thyroid surgery using a gasless, transaxillary approach and the da Vinci S system: The operative outcomes of 338 consecutive patients," has garnered 447 citations, demonstrating its profound impact on surgical practice. This work, along with his early experience detailed in "Robot-assisted endoscopic surgery for thyroid cancer: experience with the first 100 patients" (386 citations), provided the foundational evidence for the safety and feasibility of this approach. He further validated its oncologic effectiveness by proving its surgical completeness is comparable to conventional open surgery. Extending his expertise, Dr. Lee has also explored the comparative outcomes of robotic versus laparoscopic surgery for rectal cancer. Through his high-impact, practice-changing research, Dr. Lee has become a leading authority in robotic head and neck surgery, shaping modern standards of care for patients worldwide.